These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38022600)

  • 1. High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia.
    Stefańska K; Kurkowiak M; Piekarska K; Chruściel E; Zamkowska D; Jassem-Bobowicz J; Adamski P; Świątkowska-Stodulska R; Abacjew-Chmyłko A; Leszczyńska K; Zieliński M; Preis K; Zielińska H; Tymoniuk B; Trzonkowski P; Marek-Trzonkowska NM
    Front Immunol; 2023; 14():1272021. PubMed ID: 38022600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward defining the immunogenicity of HLA epitopes: Impact of HLA class I eplets on antibody formation during pregnancy.
    Hönger G; Niemann M; Schawalder L; Jones J; van Heck MR; van de Pasch LAL; Vendelbosch S; Rozemuller EH; Hösli I; Blümel S; Schaub S
    HLA; 2020 Nov; 96(5):589-600. PubMed ID: 32829523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of preeclampsia in oocyte donation pregnancies is related to the number of fetal-maternal HLA class II mismatches.
    van Bentem K; Bos M; van der Keur C; Brand-Schaaf SH; Haasnoot GW; Roelen DL; Eikmans M; Heidt S; Claas FHJ; Lashley EELO; van der Hoorn MLP
    J Reprod Immunol; 2020 Feb; 137():103074. PubMed ID: 31864034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal-Fetal HLA Compatibility in Uncomplicated and Preeclamptic Naturally Conceived Pregnancies.
    van 't Hof LJ; Schotvanger N; Haasnoot GW; van der Keur C; Roelen DL; Lashley LEELO; Claas FHJ; Eikmans M; van der Hoorn MP
    Front Immunol; 2021; 12():673131. PubMed ID: 34054856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
    Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
    Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
    Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.
    Bezstarosti S; Kramer CSM; Claas FHJ; de Fijter JW; Reinders MEJ; Heidt S
    Hum Immunol; 2022 Mar; 83(3):256-263. PubMed ID: 34963506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.
    Larkins NG; D'Orsogna L; Taverniti A; Sharma A; Chakera A; Chan D; Krishnan A; Wong G; Lim WH
    Front Immunol; 2022; 13():844438. PubMed ID: 35799779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and fetal human leukocyte antigen class Ia and II alleles in severe preeclampsia and eclampsia.
    Emmery J; Hachmon R; Pyo CW; Nelson WC; Geraghty DE; Andersen AM; Melbye M; Hviid TV
    Genes Immun; 2016 Jun; 17(4):251-60. PubMed ID: 27121092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
    Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
    Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia.
    Johnsen GM; Størvold GL; Drabbels JJM; Haasnoot GW; Eikmans M; Spruyt-Gerritse MJ; Alnæs-Katjavivi P; Scherjon SA; Redman CWG; Claas FHJ; Staff AC
    J Reprod Immunol; 2018 Sep; 129():23-29. PubMed ID: 30055414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
    Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
    Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker.
    Kosmoliaptsis V; Bradley JA; Sharples LD; Chaudhry A; Key T; Goodman RS; Taylor CJ
    Transplantation; 2008 Jun; 85(12):1817-25. PubMed ID: 18580476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.
    Kramer CSM; Bezstarosti S; Franke-van Dijk MEI; Vergunst M; Roelen DL; Uyar-Mercankaya M; Voogt-Bakker KH; Heidt S
    HLA; 2024 Jan; 103(1):e15345. PubMed ID: 38239050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-reactive class I epitopes defined by pairs of mismatched eplets and self-eplets.
    Resse M; Paolillo R; Minucci BP; Moccia G; Napoli C
    Tissue Antigens; 2015 Nov; 86(5):368-72. PubMed ID: 26373475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
    Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
    Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis.
    Dunk CE; Bucher M; Zhang J; Hayder H; Geraghty DE; Lye SJ; Myatt L; Hackmon R
    Am J Obstet Gynecol; 2022 Oct; 227(4):641.e1-641.e13. PubMed ID: 35863458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
    Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
    Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal-fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa.
    Triche EW; Harland KK; Field EH; Rubenstein LM; Saftlas AF
    J Reprod Immunol; 2014 Mar; 101-102():111-119. PubMed ID: 23998333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.